Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June -
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
- 2020 -
2021
-
2022
-
2023
-
2024
June 2020 - 56 products
IP
CI
CM
Ibuprofen Viatris
20
2.37
11.80
10 %
Effervescent granulate: Ibuprofenum 600 mg
Viatris Pharma GmbH
●
B / SL / SG
FB
G
IP
CI
CM
Ibuprofen Viatris 200 mg
30
1.43
10.80
10 %
Coated tablets: Ibuprofenum 200 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CM
Ibuprofen Viatris 400 mg
20
1.56
10.95
10 %
Coated tablets: Ibuprofenum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CM
Ibuprofen Viatris 400 mg
50
3.37
12.90
10 %
Coated tablets: Ibuprofenum 400 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CM
Ibuprofen Viatris 600 mg
20
2.16
11.60
10 %
Coated tablets: Ibuprofenum 600 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CM
Ibuprofen Viatris 600 mg
100
9.17
26.40
10 %
Coated tablets: Ibuprofenum 600 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Ibuprofen Viatris retard
20
3.90
13.50
10 %
Coated tablets: Ibuprofenum 800 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Ibuprofen Viatris retard
50
8.48
25.65
10 %
Coated tablets: Ibuprofenum 800 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Ibuprofen Viatris retard
100
15.08
32.85
10 %
Coated tablets: Ibuprofenum 800 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Treprostinil OrPha 1
mg/ml
10 ml
1088.35
1200.05
10 %
Infusion solution: Treprostinilum 1 mg/ml
OrPha Swiss GmbH
B / SL / SG
FB
G
L
IP
Treprostinil OrPha 2.5
mg/ml
10 ml
2225.56
2436.85
10 %
Infusion solution: Treprostinilum 2.5 mg/ml
OrPha Swiss GmbH
B / SL / SG
FB
G
L
IP
Treprostinil OrPha 5
mg/ml
10 ml
4451.12
4857.30
10 %
Infusion solution: Treprostinilum 5 mg/ml
OrPha Swiss GmbH
B / SL / SG
FB
G
L
IP
Treprostinil OrPha 10
mg/ml
10 ml
8902.24
9441.50
10 %
Infusion solution: Treprostinilum 10 mg/ml
OrPha Swiss GmbH
B / SL / SG
FB
G
IP
CI
Co-Valsartan Spirig HC
80/12.5 mg
28
8.93
26.15
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Co-Valsartan Spirig HC
80/12.5 mg
98
28.85
47.90
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Co-Valsartan Spirig HC
160/12.5 mg
28
10.59
28.00
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Co-Valsartan Spirig HC
160/12.5 mg
98
37.04
56.85
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Co-Valsartan Spirig HC
160/25 mg
28
10.59
28.00
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Co-Valsartan Spirig HC
160/25 mg
98
37.04
56.85
10 %
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Valsartan Spirig HC 80 mg
28
8.09
25.25
10 %
Coated tablets: Valsartanum 80 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Valsartan Spirig HC 80 mg
98
26.13
45.10
10 %
Coated tablets: Valsartanum 80 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
Valsartan Spirig HC 160 mg
28
9.73
27.05
10 %
Coated tablets: Valsartanum 160 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
Valsartan Spirig HC 160 mg
98
34.37
54.20
10 %
Coated tablets: Valsartanum 160 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
CM
Torasemid Mylan 2,5 mg
20
10.20
10 %
Tablets: Torasemidum 2.5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Torasemid Mylan 2,5 mg
100
3.93
13.50
10 %
Tablets: Torasemidum 2.5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 5 mg
20
1.38
10.75
10 %
Tablets: Torasemidum 5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 5 mg
100
6.10
15.85
10 %
Tablets: Torasemidum 5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 10 mg
20
2.04
11.45
10 %
Tablets: Torasemidum 10 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 10 mg
100
10.22
27.55
10 %
Tablets: Torasemidum 10 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 200 mg
20
11.09
28.40
10 %
Tablets: Torasemidum 200 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CM
Torasemid Mylan 200 mg
100
49.56
70.05
10 %
Tablets: Torasemidum 200 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CI
Inhixa 2000 IE (20 mg)
10
15.04
32.75
10 %
Injection solution: Enoxaparinum Natricum 20 mg
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
Inhixa 2000 IE (20 mg)
50
75.21
98.20
10 %
Injection solution: Enoxaparinum Natricum 20 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 4000 IE (40 mg)
2
5.60
15.30
10 %
Injection solution: Enoxaparinum Natricum 40 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 4000 IE (40 mg)
10
28.14
47.00
10 %
Injection solution: Enoxaparinum Natricum 40 mg
Viatris Pharma GmbH
B / SL
FB
G
L
IP
Inhixa 4000 IE (40 mg)
50
140.69
169.40
10 %
Injection solution: Enoxaparinum Natricum 40 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 6000 IE (60 mg)
10
36.74
56.35
10 %
Injection solution: Enoxaparinum Natricum 60 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 8000 IE (80 mg)
10
52.47
73.50
10 %
Injection solution: Enoxaparinum Natricum 80 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 10000 IE (100 mg)
10
65.56
87.70
10 %
Injection solution: Enoxaparinum Natricum 100 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 12000 IE (120 mg)
10
72.36
95.10
10 %
Injection solution: Enoxaparinum Natricum 120 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa 15000 IE (150 mg)
10
88.52
112.70
10 %
Injection solution: Enoxaparinum Natricum 150 mg
Viatris Pharma GmbH
B / SL
FB
G
IP
Inhixa Multi 30000 IE
(300 mg)
16.59
34.45
10 %
Injection solution: Enoxaparinum Natricum 300 mg
Viatris Pharma GmbH
B / SL
FB
G
L
IP
CI
NUBEQA 300 mg
112
2930.21
3203.20
10 %
Coated tablets: Darolutamidum 300 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
Baqsimi
50.68
71.55
10 %
poudre nasale: Glucagonum 3 mg
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Inhixa 2000 IE (20 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 20 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 6000 IE (60 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 60 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 6000 IE (60 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 60 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 8000 IE (80 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 80 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 8000 IE (80 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 80 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 10000 IE (100 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 100 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 10000 IE (100 mg)
50
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 100 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 12000 IE (120 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 120 mg
Viatris Pharma GmbH
B
FB
G
IP
Inhixa 15000 IE (150 mg)
2
PR
PR
k.A.
Injection solution: Enoxaparinum Natricum 150 mg
Viatris Pharma GmbH
B
FB
G
IP
V/S
Berinert SC 2000 IU
/ 0 UI
PR
PR
k.A.
Lyophilisate and solvent: C1-esterasi Inhibitor Humanus 2000 UI
CSL Behring AG
B
FB
G
IP
Eotriz 4 mg/5 ml
PR
PR
k.A.
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
SciClone
Pharmaceuticals
Switzerland GmbH
B
FB
G
IP
CI
Valsartan Spirig HC 40 mg
28
PR
PR
k.A.
Coated tablets: Valsartanum 40 mg
Spirig HealthCare AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
